Coy Fehnel <iwcgdw@basalball.com> To: <root-bugs@pcroot.cern.ch>, <roottalk@pcroot.cern.ch> Subject: TTTP.OB..stock pick of the week! vsemav Date: Tue, 04 May 2004 11:02:34 -0400 MIME-Version: 1.0 X-Virus-Status: Scanned by norton Content-Type: text/html; charset=us-ascii Content-Transfer-Encoding: plain <html><body> <!--qntyof-->,.Hot Trading Alert..<!--gqupap--> <p> Get..OTCBB:_TTTP.OB,..Tue, 04 May 2004 11:03:58 -0400</p> <p>Introduces VisionKare(TM) an Eye Specific Supplement<br> for Macular Degeneration.266338fEx7J2663wJ12mwJ)</p> <p><strong><font color="#FF0000">TARGET PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80<br> TARGET PRICE IN NEXT 10 DAYS: $0.92 </font></strong></p> <p> <!--qcmfjk--> ++ EXCITING NEWS JUST RELEASED FOR TTTP ++</p> <p>Before we start with the profile of TTTP we would like to mention something very important: <br> THERE IS BIG PR CAMPAIGN STARTING on May 4th ITS EXPECTED THERE WILL BE HUGE DEMAND FOR<br> TTTP SHARES.</p> <p>SO TAKE ADVANTAGE AND GET IN EARLY. THE TARGET PRICES BELOW ARE PRETTY MUCH REALISTIC. </p> <p>+>+>+>Company Profile +>+>+> </p> <p><font color="#FF0000"><strong>Symbol: TTTP.OB</strong></font> <!--qtawmp--> <br> <strong><font color="#FF0000">Current Price: $0.16</font></strong><br> <strong><font color="#FF0000">TARGET PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80<br> TARGET PRICE IN NEXT 10 DAYS: $0.92 </font></strong></p> <p>How many times have you seen good stocks but you couldn't get your hands on them in the right <br> moment? We are alerting you to a special company with a unique product that is set to be profiled <br> by many newsletters in the next 5-10 days -- this is your chance to get in!</p> <p>----------------------------------------------</p> <p><font color="#FF0000"><strong>ABOUT THE COMPANY</strong></font></p> <p>TTTP is an innovative company with a 21st century approach to the health issues of today. Unlike traditional treatment regimens, TTTP’s approach focuses on less harmful and more natural forms of therapies that yield effective results while minimizing chemical dependence or harsh side effects. 12 to 20 Plus’ believes it has a successful prescription for growth—attracting, retaining and successfully treating integrative health-conscious consumers. 12 to 20 Plus has the products to fit the dynamics and trends of a global market. We Expect some strong demand for this stock in the near future!!!!!</p> <p>----------------------------------------------</p> <p><font color="#FF0000"><strong>NEWS RELEASE</strong></font></p> <p>SAN LUIS OBISPO, CA,, Apr. 30, 2004 (MARKET WIRE via COMTEX) -- (TTTP.OB) -- According to a recent poll, Americans dread blindness more than any other disability. Recent studies indicate that by the year 2025, the population of people over the age of 65 in the United States will be six times higher than in 1990. The reason -- "baby boomers" are aging and overall life expectancy is increasing. Since many people diagnosed with macular degeneration are over age 55, the number of cases of macular degeneration in the U.S. will increase significantly as baby boomers age. </p> <p>Said Carol Slavin, President "The market is very large, with about 50 million AMD sufferers worldwide (15 million in the U.S.) and five million new cases each year. Less than 2% of all AMD cases are treated successfully, so an urgent need exists for effective new strategies." We would anticipate significant revenues in the millions of dollars as we increase our distribution capabilities and our VisionKare(TM) brand becomes the "benchmark" for the industry.</p> <p>----------------------------------------------</p> <p>*Forward-Looking...Statements-Disclaimer.,udrawr</p> <p>Information within this email contains forward looking statements; within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to <br> predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." </p> <p>Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will," "part of: "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. Please have in mind that the interpretation <br> of the witer of this newsletter about the news published by the company does not represent the company official statement and in fact may differ from the real meaning of what the news release meant to say. Please read the news release by yourself and judge by yourself about the details in it.</p> <p>tnvqax gxghvr rwxtus yhqqhx rqxogw hwlpvr tmuljv eoedxu gvjaok whvgei ccvvoq aonfet </p> </body> </html>
This archive was generated by hypermail 2b29 : Sun Jan 02 2005 - 05:50:07 MET